Updated Results From the Phase 1/2 MajesTEC-1 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Popat, R (author)

Usmani, SZ (author)

Garfall, A (author)

show more...

van de Donk, N (author)

Nahi, H (author)

Karolinska Institutet

San-Miguel, JF (author)

Oriol, A (author)

Nooka, A (author)

Martin, T (author)

Rosinol, L (author)

Chari, A (author)

Karlin, L (author)

Benboubker, L (author)

Mateos, MV (author)

Bahlis, N (author)

Moreau, P (author)

Besemer, B (author)

Martinez-Lopez, J (author)

Sidana, S (author)

Pei, LX (author)

Trancucci, D (author)

Verona, R (author)

Girgis, S (author)

Olyslager, Y (author)

Jaffe, M (author)

Uhlar, C (author)

Stephenson, T (author)

Van Rampelbergh, R (author)

Banerjee, A (author)

Goldberg, JD (author)

Kobos, R (author)

Krishnan, A (author)

show less...

 (creator_code:org_t)

2022

2022

English.

In: BRITISH JOURNAL OF HAEMATOLOGY. - 0007-1048. ; 197, s. 35-36

Related links:

http://kipublication...

• Conference paper (other academic/artistic)